株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

アプタマーの世界市場予測 2020年:DNAアプタマー・RNAアプタマー・XNAアプタマー

Aptamers Market by Type (DNA, RNA, XNA), Application (Diagnostics, Therapeutics, R&D), Technology (SELEX, Other Technologies) & by End Users (Academic Research Institutes, Biotechnology & Pharmaceutical Companies, CRO) - Global Forecast to 2020

発行 MarketsandMarkets 商品コード 275325
出版日 ページ情報 英文 133 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
アプタマーの世界市場予測 2020年:DNAアプタマー・RNAアプタマー・XNAアプタマー Aptamers Market by Type (DNA, RNA, XNA), Application (Diagnostics, Therapeutics, R&D), Technology (SELEX, Other Technologies) & by End Users (Academic Research Institutes, Biotechnology & Pharmaceutical Companies, CRO) - Global Forecast to 2020
出版日: 2015年06月29日 ページ情報: 英文 133 Pages
概要

世界のアプタマー市場は、2015年から2020年にかけて17.89%のCAGRで拡大し、2015年の1億756万米ドルから2020年までに2億4,493万米ドルに達すると予測されています。2015年において診断用途はアプタマー市場で最大のシェアを占める見込みです。治療薬開発用途は、2015年から2020年の間に最も急成長する用途の一つになると予測されています。

当レポートでは、世界のアプタマー市場について調査し、製品開発動向、競合情勢の評価、および市場発展動向などを分析しており、種類・用途・エンドユーザー・技術・地域別の市場分析と予測、主要企業のプロファイルなどをまとめ、お届けいたします。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 世界のアプタマー市場における収益の大きな機会
  • ライフサイクル分析:地域別

第5章 市場概要

  • イントロダクション
  • 市場区分
    • 種類別
    • 用途別
    • 技術別
    • エンドユーザー別
  • 市場ダイナミクス
    • 促進因子
    • 阻害因子
    • 機会

第6章 アプタマー市場:種類別

  • イントロダクション
  • DNAアプタマー
  • RNAアプタマー
  • XNAアプタマー

第7章 アプタマー市場:用途別

  • イントロダクション
  • 診断
  • 治療法開発
  • 研究開発
  • その他の用途

第8章 アプタマー市場:技術別

  • イントロダクション
  • SELEX法
  • その他の技術

第9章 アプタマー市場:エンドユーザー別

  • イントロダクション
  • 大学・政府研究機関
  • バイオテクノロジー・医薬品企業
  • 開発業務受託機関 (CRO)
  • その他のユーザー

第10章 世界のアプタマー市場:地域別

  • イントロダクション
  • 南北アメリカ
    • 米国
    • カナダ
    • ラテンアメリカ
  • 欧州
  • アジア
  • その他 (ROW)

第11章 競合環境

  • イントロダクション
  • 競合状況・動向

第12章 企業プロファイル

  • AM BIOTECHNOLOGIES, LLC
  • APTAGEN, LLC
  • APTAMER SCIENCES INC.
  • APTAMER SOLUTIONS LTD.
  • APTUS BIOTECH S.L.
  • BASE PAIR BIOTECHNOLOGIES, INC.
  • NEOVENTURES BIOTECHNOLOGY INC.
  • SOMALOGIC, INC.
  • TRILINK BIOTECHNOLOGIES, INC.
  • VIVONICS, INC.

第13章 付録

図表リスト

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: BT 3550

The global aptamers market is expected to reach $244.93 million by 2020 from $107.56 million in 2015, growing at a CAGR of 17.89% between 2015 and 2020. The aptamer type segments included in this report are DNA-based aptamers, RNA-based aptamers, and XNA-based aptamers. Based on applications, the report is segmented into diagnostics, therapeutics development, R&D, and other applications. Diagnostics applications will hold the largest share of the aptamers market in 2015. The therapeutics development application is expected to be one of the fastest-growing applications between 2015 and 2020.

The geographic segments included in this report are the Americas, Europe, Asia, and the Rest of the World (RoW). The geographic analysis reveals that the Americas are expected to account for the largest share in the global aptamers market in 2015. Europe is expected to register the fastest growth.

Market growth is majorly driven by the availability of R&D investments in biotechnology and pharmaceutical industries. Furthermore, the patent expiration of systematic evolution of ligands by exponential enrichment technology (SELEX), technological advancements, and the low cost and high efficiency of aptamers in binding to large molecules as compared to antibodies will aid the growth of the global aptamers market.

A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the global aptamers market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates. The report provides qualitative insights about growth rates, and market drivers for all important subsegments. It maps market sizes and growth rates of each subsegment and identifies segments poised for rapid growth in each geographic segment. The report also includes company profiles of market leaders.

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.

The report provides insights on the following:

  • Product Development:Product portfolios of the top players in the aptamers market.
  • Competitive Assessment:In-depth assessment of the business segments and product portfolios of the leading players in the aptamers market.
  • Market Development:Comprehensive information about lucrative emerging markets. The report analyzes the market for various aptamers products across geographies.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
    • 1.2.1. MARKET COVERED
    • 1.2.2. YEARS CONSIDERED IN THE REPORT
  • 1.3. CURRENCY
  • 1.4. STAKEHOLDERS
  • 1.5. LIMITATIONS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
    • 2.2.1. KEY DATA FROM SECONDARY SOURCES
    • 2.2.2. KEY DATA FROM PRIMARY SOURCES
    • 2.2.3. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. LUCRATIVE OPPORTUNITIES IN THE GLOBAL APTAMERS MARKET
  • 4.2. LIFE CYCLE ANALYSIS, BY REGION (2015-2020)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
    • 5.2.1. BY TYPE
    • 5.2.2. BY APPLICATION
    • 5.2.3. BY TECHNOLOGY
    • 5.2.4. BY END USER
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Strong trend of R&D investments in biotechnology and pharmaceutical companies
      • 5.3.1.2. Technological advancements
      • 5.3.1.3. Patent expiration of SELEX
      • 5.3.1.4. Low-cost and high-efficiency as compared to antibodies
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. Low market acceptance
      • 5.3.2.2. Lack of trained professionals
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Applications in other industries

6. APTAMERS MARKET, BY TYPE

  • 6.1. INTRODUCTION
  • 6.2. DNA-BASED APTAMERS
  • 6.3. RNA-BASED APTAMERS
  • 6.4. XNA-BASED APTAMERS

7. APTAMERS MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. DIAGNOSTICS
  • 7.3. THERAPEUTICS DEVELOPMENT
  • 7.4. RESEARCH AND DEVELOPMENT
  • 7.5. OTHER APPLICATIONS

8. APTAMERS MARKET, BY TECHNOLOGY

  • 8.1. INTRODUCTION
  • 8.2. SELEX
  • 8.3. OTHER TECHNOLOGIES

9. APTAMERS MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES
  • 9.3. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
  • 9.4. CONTRACT RESEARCH ORGANIZATIONS
  • 9.5. OTHER END USERS

10. GLOBAL APTAMERS MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. AMERICAS
    • 10.2.1. U.S.
    • 10.2.2. CANADA
    • 10.2.3. LATIN AMERICA
  • 10.3. EUROPE
  • 10.4. ASIA
  • 10.5. REST OF THE WORLD (ROW)

11. COMPETITIVE LANDSCAPE

  • 11.1. INTRODUCTION
  • 11.2. COMPETITIVE SITUATION AND TRENDS
    • 11.2.1. AGREEMENTS, COLLABORATIONS, EXPANSIONS, AND PARTNERSHIPS
    • 11.2.2. CONTRACTS, DEVELOPMENT AGREEMENTS, FUNDING, GRANTS, AND REWARDS
    • 11.2.3. NEW PRODUCT LAUNCHES
    • 11.2.4. OTHER DEVELOPMENTS

12. COMPANY PROFILES

  • 12.1. AM BIOTECHNOLOGIES, LLC
    • 12.1.1. BUSINESS OVERVIEW
    • 12.1.2. PRODUCT AND SERVICES
    • 12.1.3. NEWS/EVENTS
  • 12.2. APTAGEN, LLC
    • 12.2.1. BUSINESS OVERVIEW
    • 12.2.2. PRODUCT AND SERVICES
    • 12.2.3. NEWS/EVENTS
  • 12.3. APTAMER SCIENCES INC.
    • 12.3.1. BUSINESS OVERVIEW
    • 12.3.2. PRODUCT AND SERVICES
    • 12.3.3. NEWS/EVENTS
  • 12.4. APTAMER SOLUTIONS LTD.
    • 12.4.1. BUSINESS OVERVIEW
    • 12.4.2. PRODUCT AND SERVICES
    • 12.4.3. NEWS/EVENTS
  • 12.5. APTUS BIOTECH S.L.
    • 12.5.1. BUSINESS OVERVIEW
    • 12.5.2. PRODUCT AND SERVICES
    • 12.5.3. NEWS/EVENTS
  • 12.6. BASE PAIR BIOTECHNOLOGIES, INC.
    • 12.6.1. BUSINESS OVERVIEW
    • 12.6.2. PRODUCT AND SERVICES
    • 12.6.3. NEWS/EVENTS
  • 12.7. NEOVENTURES BIOTECHNOLOGY INC.
    • 12.7.1. BUSINESS OVERVIEW
    • 12.7.2. PRODUCT AND SERVICES
    • 12.7.3. NEWS/EVENTS
  • 12.8. SOMALOGIC, INC.
    • 12.8.1. BUSINESS OVERVIEW
    • 12.8.2. PRODUCT AND SERVICES
    • 12.8.3. NEWS/EVENTS
  • 12.9. TRILINK BIOTECHNOLOGIES, INC.
    • 12.9.1. BUSINESS OVERVIEW
    • 12.9.2. PRODUCT AND SERVICES
    • 12.9.3. NEWS/EVENTS
  • 12.10. VIVONICS, INC.
    • 12.10.1. BUSINESS OVERVIEW
    • 12.10.2. PRODUCT AND SERVICES
    • 12.10.3. NEWS/EVENTS

13. APPENDIX

  • 13.1. INSIGHTS OF INDUSTRY EXPERTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.4. AVAILABLE CUSTOMIZATIONS
  • 13.5. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: APTAMERS MARKET SUMMARY
  • TABLE 2: INCREASING R&D INVESTMENTS BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES IS PROPELLING THE GROWTH OF THE APTAMERS MARKET
  • TABLE 3: LOW MARKET ACCEPTANCE OF APTAMERS AS COMPARED TO ANTIBODIES WOULD RESTRICT THE MARKET GROWTH
  • TABLE 4: APPLICATIONS IN OTHER INDUSTRIES PRESENT SIGNIFICANT GROWTH OPPORTUNITIES FOR THE APTAMERS MARKET
  • TABLE 5: APTAMERS MARKET SIZE, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 6: DNA-BASED APTAMERS GENERATED AGAINST VARIOUS LIGANDS
  • TABLE 7: DNA-BASED APTAMERS MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 8: AMERICAS: DNA-BASED APTAMERS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 9: RNA-BASED APTAMERS GENERATED AGAINST VARIOUS LIGANDS
  • TABLE 10: RNA-BASED APTAMERS MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 11: AMERICAS: RNA-BASED APTAMERS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 12: COMMON CHEMICAL MODIFICATIONS OF APTAMERS FOR TUMOR TARGETING
  • TABLE 13: XNA-BASED APTAMERS MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 14: AMERICAS: XNA-BASED APTAMERS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 15: APTAMERS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 16: LIST OF RNA APTAMER SEQUENCES AND THEIR TARGETS FOR TARGETED THERAPY AND THEIR DIAGNOSTIC APPLICATIONS
  • TABLE 17: APTAMERS MARKET SIZE FOR DIAGNOSTICS APPLICATION, BY REGION, 2013-2020 ($MILLION)
  • TABLE 18: THE AMERICAS: APTAMERS MARKET SIZE FOR DIAGNOSTICS, BY REGION, 2013-2020 ($MILLION)
  • TABLE 19: STATUS OF APTAMER THERAPEUTICS UNDERGOING CLINICAL TRAILS
  • TABLE 20: APTAMERS MARKET SIZE FOR THERAPEUTICS DEVELOPMENT APPLICATION, BY REGION, 2013-2020 ($MILLION)
  • TABLE 21: AMERICAS: APTAMERS MARKET SIZE FOR THERAPEUTICS DEVELOPMENT, BY REGION, 2013-2020 ($MILLION)
  • TABLE 22: APTAMERS MARKET SIZE FOR RESEARCH AND DEVELOPMENT, BY REGION, 2013-2020 ($MILLION)
  • TABLE 23: AMERICAS: APTAMERS MARKET SIZE FOR RESEARCH AND DEVELOPMENT, BY REGION, 2013-2020 ($MILLION)
  • TABLE 24: APTAMERS MARKET SIZE FOR OTHER APPLICATIONS, BY REGION, 2013-2020 ($MILLION)
  • TABLE 25: AMERICAS: APTAMERS MARKET SIZE FOR OTHER APPLICATIONS, BY REGION, 2013-2020 ($MILLION)
  • TABLE 26: APTAMERS MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
  • TABLE 27: LIST OF MODIFICATIONS TO THE SELEX PROCESS AND THEIR DESCRIPTIONS
  • TABLE 28: APTAMERS MARKET SIZE FOR SELEX, BY REGION, 2013-2020 ($MILLION)
  • TABLE 29: AMERICAS: APTAMERS MARKET SIZE FOR SELEX, BY REGION, 2013-2020 ($MILLION)
  • TABLE 30: APTAMERS MARKET SIZE FOR OTHER TECHNOLOGIES, BY REGION, 2013-2020 ($MILLION)
  • TABLE 31: AMERICAS: APTAMERS MARKET SIZE FOR OTHER TECHNOLOGIES, BY REGION, 2013-2020 ($MILLION)
  • TABLE 32: APTAMERS MARKET SIZE, BY END USER, 2013-2020 ($MILLION)
  • TABLE 33: APTAMERS MARKET SIZE FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2013-2020 ($MILLION)
  • TABLE 34: AMERICAS: APTAMERS MARKET SIZE FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 35: APTAMERS MARKET SIZE FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2013-2020 ($MILLION)
  • TABLE 36: AMERICAS: APTAMERS MARKET SIZE FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 37: APTAMERS MARKET SIZE FOR CROS, BY REGION, 2013-2020 ($MILLION)
  • TABLE 38: AMERICAS: APTAMERS MARKET SIZE FOR CROS, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 39: APTAMERS MARKET SIZE FOR OTHER END USERS, BY REGION, 2013-2020 ($MILLION)
  • TABLE 40: AMERICAS: APTAMERS MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 41: APTAMERS MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 42: AMERICAS: APTAMERS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 43: AMERICAS: APTAMERS MARKET SIZE, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 44: AMERICAS: APTAMERS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 45: AMERICAS: APTAMERS MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
  • TABLE 46: AMERICAS: APTAMERS MARKET SIZE, BY END USER, 2013-2020 ($MILLION)
  • TABLE 47: U.S.: APTAMERS MARKET SIZE, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 48: U.S.: APTAMERS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 49: U.S.: APTAMERS MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
  • TABLE 50: U.S.: APTAMERS MARKET SIZE, BY END USER, 2013-2020 ($MILLION)
  • TABLE 51: CANADA: APTAMERS MARKET SIZE, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 52: CANADA: APTAMERS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 53: CANADA: APTAMERS MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
  • TABLE 54: CANADA: APTAMERS MARKET SIZE, BY END USER, 2013-2020 ($MILLION)
  • TABLE 55: LATIN AMERICA: APTAMERS MARKET SIZE, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 56: LATIN AMERICA: APTAMERS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 57: LATIN AMERICA: APTAMERS MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
  • TABLE 58: LATIN AMERICA: APTAMERS MARKET SIZE, BY END USER, 2013-2020 ($MILLION)
  • TABLE 59: EUROPE: APTAMERS MARKET SIZE, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 60: EUROPE: APTAMERS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 61: EUROPE: APTAMERS MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
  • TABLE 62: EUROPE: APTAMERS MARKET SIZE, BY END USER, 2013-2020 ($MILLION)
  • TABLE 63: ASIA: APTAMERS MARKET SIZE, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 64: ASIA: APTAMERS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 65: ASIA: APTAMERS MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
  • TABLE 66: ASIA: APTAMERS MARKET SIZE, BY END USER, 2013-2020 ($MILLION)
  • TABLE 67: ROW: APTAMERS MARKET SIZE, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 68: ROW: APTAMERS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 69: ROW: APTAMERS MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
  • TABLE 70: ROW: APTAMERS MARKET SIZE, BY END USER, 2013-2020 ($MILLION)
  • TABLE 71: AGREEMENTS, COLLABORATIONS, EXPANSIONS, AND PARTNERSHIPS, 2011-2015
  • TABLE 72: CONTRACTS, DEVELOPMENT AGREEMENTS, FUNDING, GRANTS, AND REWARDS, 2011-2015
  • TABLE 73: NEW PRODUCT LAUNCHES, 2011-2015
  • TABLE 74: OTHER DEVELOPMENTS, 2011-2015

LIST OF FIGURES

  • FIGURE 1: APTAMERS MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 5: BREAKDOWN OF PRIMARY INTERVIEWS: BY DESIGNATION AND REGION
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: APTAMERS MARKET SIZE, BY TYPE, 2015 VS. 2020 ($MILLION)
  • FIGURE 8: APTAMERS MARKET SIZE, BY APPLICATION, 2015 VS. 2020 ($MILLION)
  • FIGURE 9: APTAMERS MARKET SIZE, BY TECHNOLOGY, 2015 VS. 2020 ($MILLION)
  • FIGURE 10: APTAMERS MARKET SIZE, BY END USER, 2015 VS. 2020 ($MILLION)
  • FIGURE 11: APTAMERS MARKET SIZE, BY REGION, 2015 VS. 2020 ($MILLION)
  • FIGURE 12: GLOBAL APTAMERS MARKET TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD
  • FIGURE 13: DIAGNOSTICS APPLICATIONS TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2015
  • FIGURE 14: EUROPE TO WITNESS HIGHEST GROWTH RATE FROM 2015 TO 2020
  • FIGURE 15: EUROPEAN MARKET SHOWCASES LUCRATIVE GROWTH OPPORTUNITIES
  • FIGURE 16: APTAMERS MARKET SEGMENTATION: BY TYPE
  • FIGURE 17: APTAMERS MARKET SEGMENTATION: BY APPLICATION
  • FIGURE 18: APTAMERS MARKET SEGMENTATION: TECHNOLOGY
  • FIGURE 19: APTAMERS MARKET SEGMENTATION: BY END USER
  • FIGURE 20: STRONG TREND OF R&D INVESTMENTS BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES WILL DRIVE THE APTAMERS MARKET
  • FIGURE 21: NEW PHARMACEUTICAL DRUG LAUNCHES (2003-2013)
  • FIGURE 22: APTAMERS MARKET SEGMENTATION, BY TYPE
  • FIGURE 23: DNA-BASED APTAMERS SEGMENT COMMAND THE LARGEST SHARE OF THE APTAMERS MARKET, 2015 ($MILLION)
  • FIGURE 24: THE AMERICAS TO COMMAND THE LARGEST SHARE OF THE DNA-BASED APTAMERS MARKET BY 2020
  • FIGURE 25: THE AMERICAS TO COMMAND THE LARGEST SHARE OF THE RNA-BASED APTAMERS MARKET IN 2015
  • FIGURE 26: EUROPE TO BE THE LARGEST AND FASTEST-GROWING REGIONAL SEGMENT OF THE XNA-BASED APTAMERS MARKET BY 2020
  • FIGURE 27: APTAMERS MARKET, BY APPLICATION
  • FIGURE 28: DIAGNOSTICS APPLICATION SEGMENT COMMANDS THE LARGEST SHARE OF THE APTAMERS MARKET IN 2015 ($MILLION)
  • FIGURE 29: EUROPE, THE FASTEST-GROWING REGIONAL SEGMENT FOR DIAGNOSTICS APPLICATIONS, 2015 VS. 2020 ($MILLION)
  • FIGURE 30: AMERICAS EXPECTED TO BE THE LARGEST REGIONAL SEGMENT FOR THERAPEUTICS DEVELOPMENT APPLICATION ($MILLION)
  • FIGURE 31: AMERICAS TO DOMINATE THE R&D APPLICATION SEGMENT IN 2015
  • FIGURE 32: EUROPEAN OTHER APPLICATIONS SEGMENT TO WITNESS FASTEST GROWTH
  • FIGURE 33: APTAMERS MARKET SEGMENTATION, BY TECHNOLOGY
  • FIGURE 34: APTAMERS MARKET, BY TECHNOLOGY, 2015 VS. 2020 ($MILLION)
  • FIGURE 35: AMERICAS TO COMMAND THE LARGEST SHARE OF THE SELEX SEGMENT BY 2020
  • FIGURE 36: EUROPE WILL BE THE FASTEST-GROWING REGIONAL SEGMENT FOR OTHER TECHNOLOGIES IN 2020
  • FIGURE 37: APTAMERS MARKET SEGMENTATION, BY END USER
  • FIGURE 38: APTAMERS MARKET SIZE, BY END USER, 2015 VS. 2020 ($MILLION)
  • FIGURE 39: PUBLIC-SECTOR RESEARCH FUNDING IS DRIVING THE GROWTH OF THE ACADEMIC & GOVERNMENT RESEARCH INSTITUTES MARKET
  • FIGURE 40: THE AMERICAS DOMINATE THE APTAMERS MARKET FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES
  • FIGURE 41: NUMBER OF BIOTECHNOLOGY AND PHARMACEUTICAL PATENTS GRANTED IN 2012, BY REGION
  • FIGURE 42: BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES SEGMENT TO WITNESS THE HIGHEST GROWTH IN EUROPE
  • FIGURE 43: THE AMERICAS ARE EXPECTED TO DOMINATE THE APTAMERS MARKET FOR CROS
  • FIGURE 44: EUROPE TO WITNESS HIGHEST GROWTH IN THE APTAMERS MARKET FOR OTHER END USERS IN THE FORECAST PERIOD
  • FIGURE 45: APTAMERS MARKET SEGMENTATION, BY REGION
  • FIGURE 46: AMERICAS TO DOMINATE THE GLOBAL APTAMERS MARKET
  • FIGURE 47: APTAMERS MARKET IN EUROPE TO WITNESS THE HIGHEST GROWTH FROM 2015 TO 2020
  • FIGURE 48: AMERICAS: MARKET SNAPSHOT
  • FIGURE 49: U.S. TO DOMINATE THE APTAMERS MARKET IN THE AMERICAS
  • FIGURE 50: DNA-BASED APTAMERS TO COMMAND THE LARGEST SHARE OF THE APTAMERS MARKET IN THE AMERICAS
  • FIGURE 51: DIAGNOSTICS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE APTAMERS APPLICATIONS MARKET IN AMERICAS
  • FIGURE 52: SELEX FORMED THE LARGEST TECHNOLOGY SEGMENT IN THE AMERICAS
  • FIGURE 53: ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES FORMED THE LARGEST END-USER SEGMENT IN THE AMERICAS
  • FIGURE 54: EUROPE: MARKET SNAPSHOT
  • FIGURE 55: DNA-BASED APTAMERS TO COMMAND THE LARGEST SHARE OF THE EUROPEAN APTAMERS MARKET
  • FIGURE 56: DIAGNOSTICS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE APTAMERS APPLICATIONS MARKET IN EUROPE
  • FIGURE 57: SELEX FORMED THE LARGEST TECHNOLOGY SEGMENT IN EUROPE
  • FIGURE 58: ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES ACCOUNT FOR THE LARGEST SHARE OF THE APTAMERS END-USERS MARKET IN EUROPE
  • FIGURE 59: DNA-BASED APTAMERS TO COMMAND THE LARGEST SHARE OF THE APTAMERS MARKET IN ASIA
  • FIGURE 60: DIAGNOSTICS APPLICATION SEGMENT TO DOMINATE THE APTAMERS MARKET IN ASIA
  • FIGURE 61: SELEX SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE APTAMERS TECHNOLOGIES MARKET IN ASIA
  • FIGURE 62: ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES TO ACCOUNT FOR THE LARGEST SHARE OF THE APTAMERS END-USER MARKET IN ASIA
  • FIGURE 63: DNA-BASED APTAMERS TO COMMAND THE LARGEST SHARE OF THE ROW APTAMERS MARKET
  • FIGURE 64: THE DIAGNOSTICS APPLICATION SEGMENT TO COMMAND THE LARGEST SHARE OF THE APTAMERS MARKET IN THE ROW REGION
  • FIGURE 65: THE SELEX TECHNOLOGY SEGMENT IS EXPECTED TO DOMINATE THE ROW APTAMERS MARKET IN 2015
  • FIGURE 66: ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES SEGMENT TO DOMINATE THE ROW MARKET FOR APTAMERS
  • FIGURE 67: GROWTH STRATEGIES: AGREEMENTS, COLLABORATIONS, EXPANSIONS, AND PARTNERSHIPS WAS THE KEY STRATEGY
Back to Top